Source: Eur Respir Mon; 2009: 46: 251–264
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
U. Specks. Pulmonary vasculitis: update on the management of ANCA-associated vasculitis. Eur Respir Mon; 2009: 46: 251–264

Member's Comments

No comment yet.

Related content which might interest you: Pulmonary vasculitis Source: ERS Course 2019 - Interstitial Lung Diseases Year: 2019 Pulmonary vasculitis Source: ERS Course 2019 - Interstitial Lung Diseases Year: 2018 Pulmonary vasculitis Source: ERS Course 2016 Year: 2016 Pulmonary vasculitis Source: ERS Courses: Interstitial Lung Diseases Year: 2019 Pulmonary manifestations of systemic vasculitis in childhood Source: Breathe, 16 (4) 200211; 10.1183/20734735.0211-2020 Year: 2020 Sarcoidosis: pulmonary manifestations and management Source: Eur Respir Monogr 2019; 86: 404-418 Year: 2019 Pulmonary haemorrhage and vasculitis in Graves’ disease Source: Breathe 2008; 6: 169-174 Year: 2009 A rare association of pulmonary hemosiderosis with normocomplementemic urticarial vasculitis in a child Source: Eur Respir J 2006; 28: Suppl. 50, 382s Year: 2006 Prevalence and outcome of pulmonary fibrosis in microscopic polyangiitis Source: Eur Respir J 2010; 36: 116-121 Year: 2010 Pulmonary manifestations of myeloperoxidase-antineutrophil cytoplasmic antibody(MPO-ANCA)-related systemic vasculitis:CT findings in 50 patients Source: Eur Respir J 2002; 20: Suppl. 38, 267s Year: 2002 Management of ANCA-associated vasculitis (AAV): A single-centre perspective from respiratory clinic. Source: International Congress 2017 – The spectrum of CTDs: from pathogenesis to treatment Year: 2017 Early outcomes of patients with systemic lupus erythematosus and antiphospholipid syndrome after pulmonary endarterectomy Source: International Congress 2016 – Pulmonary hypertension and chronic thromboembolic pulmonary hypertension Year: 2016 Pulmonary involvement at presentation determines initial disease activity and permanent organ damage in ANCA-associated vasculitis Source: Annual Congress 2007 - Imaging of pulmonary vascularisation and illustrated overview of lung pathology Year: 2007 Diffuse alveolar hemorrhage and pulmonary fibrosis in MPO-ANCA-associated vasculitides Source: Eur Respir J 2005; 26: Suppl. 49, 267s Year: 2005 Systemic manifestations of sarcoidosis Source: Eur Respir J 2006; 28: Suppl. 50, 95s Year: 2006 Radiologic finding of pulmonary vasculitis Source: Annual Congress 2009 - Old and new: technique and pathology Year: 2009 Interstitial lung disease with ANCA-associated vasculitis (AAV-ILD): Clinical features and survival compared to patients with ILD associated with systemic sclerosis and IPF Source: Virtual Congress 2020 – Addressing unresolved questions in rare diffuse parenchymal lung diseases: interdisciplinary research is the key Year: 2020 Challenges in the management of patients with ANCA- associated vasculitides Source: Annual Congress 2012 - Asthma: mechanisms of airway inflammation Year: 2012 Granulomatous angiitis leading to a pulmonary veno-occlusive disease-like picture Source: Eur Respir J 2009; 33: 666-669 Year: 2009 Pulmonary manifestations of systemic sclerosis, a report from Iran Source: Annual Congress 2011 - Rare diffuse lung diseases Year: 2011